Back

Primary endpoint is negative, what next? A statistical perspective.

29 August 2016 (08:52 - 09:15)
Organised by:
Congress Presentation Part of: Interpreting clinical trials: does a primary endpoint tell it all? Guidelines and implementation in low resource settings ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Stuart J Pocock

London School of Hygiene and Tropical Medicine, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Primary endpoint is negative, what next? A clinical perspective.
Professor M. Pfeffer (Boston, US)
Slides Video
Presentation thumbnail
Primary endpoint is positive, is that enough? A clinical perspective.
Doctor G. Stone (New York City, US)
Slides Video
Presentation thumbnail
Primary endpoint is positive, is that enough? A statistical perspective.
Professor P. Juni (Oxford, GB)
Slides Video

Access the full session

Session thumbnail
Interpreting clinical trials: does a primary endpoint tell it all?

The Event

Event poster

ESC Congress 2016

29 August 2016 08:52 CET
You may be interested in
thumbnail
Congress Presentation
Meaningful endpoints in cardiovascular outcome trials.
27 August 2022
thumbnail
Congress Presentation
Mortality and appropriate therapies in patients with HFrEF undergoing EPS before ICD implantation
31 August 2026
thumbnail
Congress Presentation
Efficacy of interleukin-1 blockade for prevention of heart failure outcomes in patients with prior myocardial Infarction: a systematic review and meta-analysis of 10301 patients
11 May 2026
thumbnail
Congress Presentation
Risks and benefits of antiplatelet therapy in patients with abdominal aortic aneurysm without symptomatic atherosclerotic disease: a nationwide cohort study
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources